Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03055533 · ClinicalTrials.gov registry record · NA
Headsprout Reading Program in Children With Autism Spectrum Disorder and Reading Delay
A NA study, sponsored by University of Nebraska.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT03055533 is a NA study that has completed, run by University of Nebraska. The registered enrollment target is 16 participants.
The verdict
NCT03055533, a NA study, has completed, sponsored by University of Nebraska.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
Headsprout is a commercially available computer-based reading program that teaches children fundamental reading skills, including phonics, fluency, and comprehension. The Headsprout reading intervention has been shown to be effective with children with various levels of reading skills, but it has not been rigorously tested in children with autism spectrum disorder (ASD). The purpose of this study is to evaluate the effectiveness of Headsprout in a pilot sample of 18 children with ASD and reading delays to serve as a foundation for a larger, future randomized clinical trial (RCT). Eighteen participants will be included in the study and randomly assigned to one of two groups; the first group will immediately receive treatment with the Headsprout reading program and the second treatment group will receive treatment after 12 weeks. Treatment sessions will occur for one to two hours, two to four days a week, for twelve weeks. The participants who do not receive treatment immediately will be asked to complete reading assessments periodically throughout their wait time. Participation may occur in clinic or via telehealth.
Interventions
- BEHAVIORAL Headsprout reading program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2018-10-01 |
| Est. Completion | 2022-06-24 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03055533
The ClinicalTrials.gov registry entry for NCT03055533 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Headsprout reading program is the first listed.
NCT03055533 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03055533 about?
NCT03055533 is a clinical study titled "Headsprout Reading Program in Children With Autism Spectrum Disorder and Reading Delay". Headsprout is a commercially available computer-based reading program that teaches children fundamental reading skills, including phonics, fluency, and comprehension. The Headsprout reading intervention has been shown to be effective with children with various levels of reading skills, but it has no...
What is the current status of trial NCT03055533?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2018-10-01. Estimated completion is 2022-06-24.
What interventions are being tested in trial NCT03055533?
The interventions under investigation include: Headsprout reading program (BEHAVIORAL).
Who is sponsoring clinical trial NCT03055533?
This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.